Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Supreme Court Of India
2002 Gujarat Riots
Enforcement Directorate (ED)
Maharashtra Government
University Grants Commission
Alt News
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVAXIN likely to get approval for children above 2yrs: Report
India

COVAXIN likely to get approval for children above 2yrs: Report

COVAXIN likely to get approval for children above 2yrs: Report
Written by Pratyush Deep Kotoky
Apr 22, 2022, 10:37 am 2 min read
COVAXIN likely to get approval for children above 2yrs: Report
A government panel is also reportedly evaluating Bharat Biotech's data on children above 2 years.

Bharat Biotech's COVID-19 vaccine, COVAXIN, is likely to get the Drugs Controller General of India's (DCGI) nod for use among children aged two to 12 years. The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) is considering sending recommendations on COVAXIN to DCGI, reported News18. A government panel is also reportedly evaluating Bharat Biotech's data on children above two years.

Context
Why does this story matter?
  • Vaccination of children has now become the government's priority as India is witnessing a fresh surge in COVID-19 cases, especially among kids.
  • Notably, India has so far not included children below 12 years in its national vaccination drive.
  • For those aged 12-18 years, two vaccines—Biological E's Corbevax (for the 12-14 years age group) and COVAXIN (for the 15-18 age group)—have so far been authorized.
Details
Bharat Biotech submitted data from its clinical trials last year

To recall, Bharat Biotech had last year submitted its data from its clinical trials in the 2-18 years age group for COVAXIN to the CDSCO. In October 2021, the SEC had also recommended emergency use authorization (EUA) of COVAXIN for children aged 2 to 18 years, but with certain conditions. However, DCGI granted later granted COVAXIN the EUA only for children above 12 years.

Information
SEC recommends Corbevax for children aged 5 to 12

Meanwhile, the SEC had earlier also reportedly recommended the use of Biological E's Corbevax in children aged 5-12 years. Also, a government panel had previously convened a meeting to discuss data and the use of Corbevax in children in this age bracket, reported News18.

COVID-19
Current COVID-19 situation in India

India on Friday reported 2,451 new COVID-19 cases and 54 more deaths in the last 24 hours. This marks an increase of nearly 100 cases from the previous day. The active caseload in the country has also been witnessing an increasing trend and stood at 14,241 on Friday. While India's total cases rose to 4,30,52,425, the recovery rate stood at 98.75%

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Pratyush Deep Kotoky
Pratyush Deep Kotoky
Twitter
Pratyush Deep Kotoky covers national and politics news at NewsBytes. His over three-year-long career involves reporting on sociopolitical issues across India, particularly the northeast region. His previous stints include 101Reporters, The Sunday Guardian, and Inshorts, and he has also written for Asia Times, Firstpost, and Newslaundry. He has a postgraduate degree in Journalism from the Indian Institute of Mass Communication, Delhi.
Latest
Drugs Controller General of India
COVID-19
Bharat Biotech
COVAXIN
COVID-19 Vaccination
Related
Latest
All-rounder Mitchell Santner tests COVID-19 positive ahead of Ireland series
All-rounder Mitchell Santner tests COVID-19 positive ahead of Ireland series Sports
What do Cristiano Ronaldo's stats say in 2021-22 at United?
What do Cristiano Ronaldo's stats say in 2021-22 at United? Sports
Happy birthday, Tom Cruise! Here are his 5 lesser-known films
Happy birthday, Tom Cruise! Here are his 5 lesser-known films Entertainment
Army rebuild bridges overnight to make way for Amarnath pilgrims
Army rebuild bridges overnight to make way for Amarnath pilgrims India
Wriddhiman Saha leaves Bengal domestic side, set to represent Tripura
Wriddhiman Saha leaves Bengal domestic side, set to represent Tripura Sports
Drugs Controller General of India
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory
COVID-19 vaccine Corbevax's samples cleared by India's apex testing laboratory India
J&J vaccine's 1cr doses ready for export after CDL nod
J&J vaccine's 1cr doses ready for export after CDL nod India
More News
COVID-19
COVID-19: India logs 16,103 fresh cases, 31 more fatalities
COVID-19: India logs 16,103 fresh cases, 31 more fatalities India
BJP to pass '2024 polls' resolution in national executive meeting
BJP to pass '2024 polls' resolution in national executive meeting Politics
Odisha: Full Jagannath Rath Yatra opens today after two years
Odisha: Full Jagannath Rath Yatra opens today after two years India
5 reasons you must have kadha every day
5 reasons you must have kadha every day Lifestyle
How to make the best of work from home
How to make the best of work from home Lifestyle
More News
Bharat Biotech
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
Are Indian vaccines effective against Omicron? Here's what manufacturers say
Are Indian vaccines effective against Omicron? Here's what manufacturers say India
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers
Australia accepts COVAXIN as 'recognized' vaccine for incoming travelers World
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO
Cannot cut corners, thorough evaluation needed for COVAXIN EUL: WHO India
More News
COVAXIN
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced
PM Modi's address: COVID-19 vaccination for 15-18-year-olds, booster doses announced India
COVAXIN found 50% effective against COVID-19 in first real-world study
COVAXIN found 50% effective against COVID-19 in first real-world study India
COVID-19: India reports 11K new cases, 526 more deaths
COVID-19: India reports 11K new cases, 526 more deaths India
COVAXIN under review; may get WHO recommendation in 24 hours
COVAXIN under review; may get WHO recommendation in 24 hours India
More News
COVID-19 Vaccination
COVID-19: India logs 14,506 fresh cases, 30 more fatalities
COVID-19: India logs 14,506 fresh cases, 30 more fatalities India
COVID-19: India logs 11,793 new cases, 27 more deaths
COVID-19: India logs 11,793 new cases, 27 more deaths India
COVID-19: India reports 17,073 new cases; 21 more deaths
COVID-19: India reports 17,073 new cases; 21 more deaths India
COVID-19 vaccines prevented 42L deaths in India in 2021: Report
COVID-19 vaccines prevented 42L deaths in India in 2021: Report India
COVID-19: India logs 17,336 new cases, highest in 4 months
COVID-19: India logs 17,336 new cases, highest in 4 months India
More News
Related
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
UK to add COVAXIN to approved vaccines from November 22
UK to add COVAXIN to approved vaccines from November 22 India
COVAXIN gets WHO approval for emergency use listing
COVAXIN gets WHO approval for emergency use listing India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022